This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Neal F Haas: Innovator in Antiplatelet Monitoring
Introduction
Neal F Haas is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in monitoring blood levels of antiplatelet compounds. His innovative approach has the potential to enhance patient care and treatment efficacy.
Latest Patents
Neal F Haas holds a patent for a method and reagent for monitoring blood levels of antiplatelet compounds. This method involves determining the amount of an antiplatelet compound in a subject's blood by calculating the ACT number and comparing it to a standardized concentration figure. Notably, this method can be applied to subjects concurrently treated with heparin and antiplatelet compounds without the need for additional heparin in the blood sample. The invention also includes reagents that immunoreact with antiplatelet compounds and kits comprising these immunoreactive reagents. He has 1 patent to his name.
Career Highlights
Neal F Haas has worked with G.D. Searle & Company, where he has been able to apply his expertise in the development of medical diagnostics. His work has contributed to advancements in the monitoring of antiplatelet therapy, which is crucial for patients undergoing treatment for various cardiovascular conditions.
Collaborations
Throughout his career, Neal has collaborated with notable colleagues such as Larry P Feigen and Christopher P Carron. These collaborations have fostered innovation and have been instrumental in the development of his patented methods.
Conclusion
Neal F Haas is a distinguished inventor whose work in antiplatelet monitoring has the potential to significantly impact patient treatment and care. His contributions to medical diagnostics exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile